Valuation: MediPal Holdings Corporation

Market Cap 674B 4.22B 3.83B 3.54B 3.2B 6.04B 396B 6.25B 42.61B 16.88B 213B 15.84B 15.5B P/E 2027 *
12.7x
P/E 2028 * 14.1x
Enterprise Value 674B 4.22B 3.83B 3.54B 3.2B 6.04B 396B 6.25B 42.61B 16.88B 213B 15.84B 15.5B EV / Sales 2027 *
0.17x
EV / Sales 2028 * 0.17x
Free-Float
87.33%
Yield 2027 *
2.27%
Yield 2028 * 2.51%
1 day-1.00%
1 week+2.16%
Current month-5.32%
1 month+4.66%
3 months+15.63%
6 months+15.51%
Current year+17.62%
1 week 3,119
Extreme 3119
3,298
1 month 3,106
Extreme 3106
3,608
Current year 2,530
Extreme 2530
3,608
1 year 2,530
Extreme 2530
3,608
3 years 2,156
Extreme 2156
3,608
5 years 1,603
Extreme 1603
3,608
10 years 1,603
Extreme 1603
3,608
Manager TitleAgeSince
Chief Executive Officer 65 2026-09-30
Chief Administrative Officer - 2025-05-31
Corporate Officer/Principal 69 2025-05-31
Director TitleAgeSince
Director/Board Member 63 2010-05-31
Director/Board Member 71 2007-05-31
Director/Board Member 54 2013-05-31
Change 5-day change 1-year change 3-year change Capi.($)
-1.00%+2.16%+24.45%+35.86% 4.22B
-0.82%+1.40%+39.64%+143.17% 1,275B
-1.12%+0.16%+44.21%+88.24% 680B
-0.16%+0.43%+26.76%+113.01% 521B
+1.14%+2.04%+43.06%+72.81% 389B
-2.23%-2.89%+55.47%+41.64% 356B
+1.27%+1.72%+30.01%+63.11% 305B
+0.37%-0.23%+3.71%+38.05% 287B
-0.72%-0.63%+37.29%+71.87% 250B
-0.30%-1.03%+34.04%+124.88% 208B
Average -0.36%+0.75%+33.86%+79.26% 428B
Weighted average by Cap. -0.47%+0.76%+36.90%+97.96%

Financials

2027 *2028 *
Net sales 3,930B 24.62B 22.37B 20.67B 18.67B 35.23B 2,312B 36.47B 249B 98.48B 1,241B 92.39B 90.43B 4,039B 25.31B 22.99B 21.24B 19.19B 36.21B 2,376B 37.49B 255B 101B 1,275B 94.97B 92.96B
Net income 52.63B 330M 300M 277M 250M 472M 30.96B 488M 3.33B 1.32B 16.62B 1.24B 1.21B 45.39B 284M 258M 239M 216M 407M 26.71B 421M 2.87B 1.14B 14.33B 1.07B 1.04B
Net Debt - -
Projected Income Statement - Annual - MediPal Holdings Corporation
Logo MediPal Holdings Corporation
Medipal Holdings Corp is a Japan-based company principally engaged in the wholesale of pharmaceuticals, cosmetics, daily necessities, and veterinary medicines. The Company operates in three segments. The Prescription Pharmaceuticals Wholesale Business segment engages in wholesale business targeting customers such as hospitals, clinics, and dispensing pharmacies. The Cosmetics, Daily Necessities, and General Pharmaceuticals Wholesale Business segment engages in wholesale business targeting customers such as drugstores, home improvement centers, convenience stores, and supermarkets. The Veterinary Medicines and Food Processing Raw Materials Wholesale Business segment engages in wholesale business targeting customers such as veterinary hospitals, livestock and fisheries producers, and processed food manufacturers. The Company also engages in preventive medicine, research and development of cutting-edge medical technology, non-life insurance agency services, and others.
Employees
13,024
Date Price Change Volume
26-11-17 JP¥3,258.00 -1.00% 292,300
26-11-16 JP¥3,291.00 +1.95% 406,500
26-11-13 JP¥3,228.00 +0.94% 297,900
26-11-12 JP¥3,198.00 +1.78% 429,800
26-11-11 JP¥3,142.00 -1.47% 433,600
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - MediPal Holdings Corporation
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
3,291.00JPY
Average target price
3,122.50JPY
Spread / Average Target
-5.12%
  1. Stock Market
  2. Stocks
  3. 7459 Stock